LONDON (AFP) – British pharmaceutical group GlaxoSmithKline (GSK) revealed yesterday that net profits slumped by almost a quarter in 2021, after the prior year was boosted by asset sales. Profit after taxation sank to just under GBP4.4 billion last year, GSK said in a statement. That compared with GBP5.7 billion in 2020, when its bottom
